Full Text View
Tabular View
Study Results
Related Studies
Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI
This study has been completed.
Study NCT00067470   Information provided by BioMarin Pharmaceutical
First Received: August 20, 2003   Last Updated: September 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Mucopolysaccharidosis VI
Additional conditions recognized in this trial
Mucopolysaccharidoses
More general conditions related to this trial
Carbohydrate Metabolism, Inborn Errors
Connective Tissue Diseases
Genetic Diseases, Inborn
Lysosomal Storage Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Mucinoses
Interventions listed in this trial
Placebo
N-acetylgalactosamine 4-sulfatase
Sponsors listed in this trial
BioMarin Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services